Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
Stefan, Norbert, Ramsauer, Markus, Jordan, Paul, Nowotny, Bettina, Kantartzis, Konstantinos, Machann, Jürgen, Hwang, Jong-Hee, Nowotny, Peter, Kahl, Sabine, Harreiter, Jürgen, Hornemann, Silke, SanyalТом:
2
Мова:
english
Журнал:
The Lancet Diabetes & Endocrinology
DOI:
10.1016/S2213-8587(13)70170-0
Date:
May, 2014
Файл:
PDF, 342 KB
english, 2014
File converter
Більше результатів пошуку
More benefits 
